Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis B vaccine immunogenicity in adults with chronic non-cirrhotic hepatitis C
RBR-10ppxgw6Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2012
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of Butang in hepatitis B (HBV) (3 arms), sponsored by Universidade de São Paulo. Primary endpoint: Seroprotective anti-HBs response after primary vaccination. Started Jun 2012; status: completed.
02
Drugs
Butang
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on RBR-10ppxgw6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-10ppxgw6.